Evinacumab for Homozygous Familial Hypercholesterolemia

dc.contributor.authorAğırbaşlı, Mehmet
dc.date.accessioned2025-05-10T19:27:42Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.issn0028-4793
dc.identifier.issn1533-4406
dc.identifier.issue6
dc.identifier.pmid33567205
dc.identifier.scopus2-s2.0-85101013539
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7047
dc.identifier.volume384
dc.identifier.wosWOS:000617621800018
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorAğırbaşlı, Mehmet
dc.language.isoen
dc.publisherMassachusetts Medical Soc
dc.relation.ispartofNew England Journal of Medicine
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleEvinacumab for Homozygous Familial Hypercholesterolemia
dc.typeLetter

Dosyalar